 | Up a level |
Tripyla, Afroditi; Ferreira, Antonio; Schönenberger, Katja A; Näf, Noah H; Inderbitzin, Lukas E; Prendin, Francesco; Cossu, Luca; Cappon, Giacomo; Facchinetti, Andrea; Herzig, David; Bally, Lia (2023). Relationship Between Symptom Perception and Postprandial Glycemic Profiles in Patients With Postbariatric Hypoglycemia After Roux-en-Y Gastric Bypass Surgery. Diabetes care, 46(10), pp. 1792-1798. American Diabetes Association 10.2337/dc23-0454
Schönenberger, Katja A; Ferreira, Antonio; Stebler, Céline; Prendin, Francesco; Gawinecka, Joanna; Nakas, Christos T; Mühlebach, Stefan; Stanga, Zeno; Facchinetti, Andrea; Herzig, David; Bally, Lia (2023). Nutritional strategies for correcting low glucose values in patients with postbariatric hypoglycaemia: A randomized controlled three-arm crossover trial. Diabetes, obesity & metabolism, 25(10), pp. 2853-2861. Wiley 10.1111/dom.15175
Ferreira, Antonio; Schönenberger, Katja; Potoczna, Natascha; Vogt, Andreas; Gerber, Philipp; Zehetner, Jörg; Giachino, Daniel; Nett, Philipp; Gawinecka, Joanna; Cossu, Luca; Fuster, Daniel; Dalla Man, Chiara; Facchinetti, Andrea; Melmer, Andreas; Nakas, Christos T; Hepprich, Matthias; Donath, Marc; Herzig, David; Bally, Lia (2023). Randomized, double-blind, placebo-controlled crossover trial of once daily empagliflozin 25 mg for the treatment of postprandial hypoglycaemia after Roux-en-Y gastric bypass. Diabetes technology & therapeutics, 25(7), pp. 467-475. Mary Ann Liebert 10.1089/dia.2023.0036
Ferreira, Antonio; Emara, Ahmed Fahiem Abdelsalam; Herzig, David; Melmer, Andreas; Vogt, Andreas P; Nakas, Christos T; Facchinetti, Andrea; Dalla Man, Chiara; Bally, Lia (2022). Study protocol for a randomised, double-blind, placebo-controlled crossover trial assessing the impact of the SGLT2 inhibitor empagliflozin on postprandial hypoglycaemia after gastric bypass. BMJ open, 12(9), e060668. 10.1136/bmjopen-2021-060668
